semaglutide gastroparesis lawsuit in louisiana nausea class action Ozempic Lawsuit: May 2026 Blindness and Claims louisiana semaglutide gastric stasis attorney
Description
not yet approved Tirzepatide : FDA-approved as Mounjaro (2022) for T2D and Zepbound (2023) for obesity Advantage : Tirzepatide Side Effect Profile# Retatrutide : GI side effects common
Full Body Wellness in One Location From energy and weight to skin and recovery, we treat the whole picture under one trusted roof
Your personalized PlexusDx plan ensures your medication aligns with your biology, not a one-size-fits-all timeline
If you lose muscle, your maintenance calories drop
Mol Cell Endocrinol (2023) 572:111954
FSA/HSA: A major plus is that their program is FSA/HSA eligible
